Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AK & MN BioFarm is a South Korean biotechnology company specializing in the development and manufacture of high-purity Omega-3 fatty acids for pharmaceutical and nutraceutical applications. Established as a joint venture between South Korea's Aekyung Group and Belgium's Minami Nutrition, the company utilizes advanced purification technologies such as molecular distillation and supercritical fluid chromatography to produce EPA and DHA concentrates. Their products serve as active pharmaceutical ingredients (APIs) for cardiovascular medications and high-end health supplements. The company operates state-of-the-art manufacturing facilities that comply with international quality standards, including EU-GMP and KDMF certifications. AK & MN BioFarm is a key global supplier of high-concentration Omega-3 oils, supporting the treatment of hypertriglyceridemia and related metabolic disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AK & MN BioFarm.